Capala J - Search Results

1

[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography.

Kramer-Marek G, Kiesewetter DO, Martiniova L, Jagoda E, Lee SB, Capala J. Kramer-Marek G, et al. Among authors: capala j. Eur J Nucl Med Mol Imaging. 2008 May;35(5):1008-18. doi: 10.1007/s00259-007-0658-0. Epub 2007 Dec 22. Eur J Nucl Med Mol Imaging. 2008. PMID: 18157531 Free PMC article.

2

Fluorescence lifetime imaging system for in vivo studies.

Hassan M, Riley J, Chernomordik V, Smith P, Pursley R, Lee SB, Capala J, Gandjbakhche AH. Hassan M, et al. Among authors: capala j. Mol Imaging. 2007 Jul-Aug;6(4):229-36. Mol Imaging. 2007. PMID: 17711778 Free PMC article.

3

Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging.

Lee SB, Hassan M, Fisher R, Chertov O, Chernomordik V, Kramer-Marek G, Gandjbakhche A, Capala J. Lee SB, et al. Among authors: capala j. Clin Cancer Res. 2008 Jun 15;14(12):3840-9. doi: 10.1158/1078-0432.CCR-07-4076. Clin Cancer Res. 2008. PMID: 18559604 Free PMC article.

4

HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.

Puri A, Kramer-Marek G, Campbell-Massa R, Yavlovich A, Tele SC, Lee SB, Clogston JD, Patri AK, Blumenthal R, Capala J. Puri A, et al. Among authors: capala j. J Liposome Res. 2008;18(4):293-307. doi: 10.1080/08982100802457377. J Liposome Res. 2008. PMID: 18937120 Free PMC article.

5

Nanoscintillator conjugates as photodynamic therapy-based radiosensitizers: calculation of required physical parameters.

Morgan NY, Kramer-Marek G, Smith PD, Camphausen K, Capala J. Morgan NY, et al. Among authors: capala j. Radiat Res. 2009 Feb;171(2):236-44. doi: 10.1667/RR1470.1. Radiat Res. 2009. PMID: 19267550 Free PMC article. Review.

6

Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules.

Kramer-Marek G, Kiesewetter DO, Capala J. Kramer-Marek G, et al. Among authors: capala j. J Nucl Med. 2009 Jul;50(7):1131-9. doi: 10.2967/jnumed.108.057695. Epub 2009 Jun 12. J Nucl Med. 2009. PMID: 19525458 Free PMC article.

7

Radiolabeling of HER2 specific Affibody(R) molecule with F-18.

Kiesewetter DO, Krämer-Marek G, Ma Y, Capala J. Kiesewetter DO, et al. Among authors: capala j. J Fluor Chem. 2008 Sep;129(9):799-805. doi: 10.1016/j.jfluchem.2008.06.021. J Fluor Chem. 2008. PMID: 19727427 Free PMC article.

8

Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.

Zielinski R, Lyakhov I, Jacobs A, Chertov O, Kramer-Marek G, Francella N, Stephen A, Fisher R, Blumenthal R, Capala J. Zielinski R, et al. Among authors: capala j. J Immunother. 2009 Oct;32(8):817-25. doi: 10.1097/CJI.0b013e3181ad4d5d. J Immunother. 2009. PMID: 19752752 Free PMC article.

9

HER2- and EGFR-specific affiprobes: novel recombinant optical probes for cell imaging.

Lyakhov I, Zielinski R, Kuban M, Kramer-Marek G, Fisher R, Chertov O, Bindu L, Capala J. Lyakhov I, et al. Among authors: capala j. Chembiochem. 2010 Feb 15;11(3):345-50. doi: 10.1002/cbic.200900532. Chembiochem. 2010. PMID: 20052708 Free PMC article.

10

Quantitative analysis of Her2 receptor expression in vivo by near-infrared optical imaging.

Chernomordik V, Hassan M, Lee SB, Zielinski R, Gandjbakhche A, Capala J. Chernomordik V, et al. Among authors: capala j. Mol Imaging. 2010 Aug;9(4):192-200. Mol Imaging. 2010. PMID: 20643022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters